Cuu Long Pharmaceutical JSC banner
C

Cuu Long Pharmaceutical JSC
VN:DCL

Watchlist Manager
Cuu Long Pharmaceutical JSC
VN:DCL
Watchlist
Price: 37 150 VND -6.89% Market Closed
Market Cap: ₫2.7T

Profitability Summary

Cuu Long Pharmaceutical JSC's profitability score is 41/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

41 / 100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

41 / 100
Profitability
Score
41 / 100
Profitability
Score

Margins

Earnings Waterfall
Cuu Long Pharmaceutical JSC

Margins Comparison
Cuu Long Pharmaceutical JSC Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
VN
Cuu Long Pharmaceutical JSC
VN:DCL
2.7T VND
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
855.1B USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
574.7B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
248.4B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
229B GBP
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
228.1B CHF
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
291.8B USD
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
244.4B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
154.6B USD
Loading...
Loading...
Loading...
UK
GlaxoSmithKline PLC
LSE:GSK
86.8B GBP
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Cuu Long Pharmaceutical JSC Competitors

Country Company Market Cap ROE ROA ROCE ROIC
VN
Cuu Long Pharmaceutical JSC
VN:DCL
2.7T VND
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
855.1B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
574.7B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
248.4B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
229B GBP
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
228.1B CHF
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
291.8B USD
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
244.4B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
154.6B USD
Loading...
Loading...
Loading...
Loading...
UK
GlaxoSmithKline PLC
LSE:GSK
86.8B GBP
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Cuu Long Pharmaceutical JSC

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett